ProQuest Management LLC
Insider CIK 1379010 · EGRX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EGRX EAGLE PHARMACEUTICALS, INC | J Other | 2016-05-20 | 2016-05-24 | 4,770,828 | — | $0 | 4,770,828 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | J Other | 2016-05-20 | 2016-05-24 | 9,360 | — | $0 | 9,360 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2016-05-13 | 2016-05-16 | 13,980 | $40.92 | $572.1K | 41,081 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2016-05-12 | 2016-05-16 | 4,000 | $40.00 | $160.0K | 55,061 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | J Other | 2015-07-01 | 2015-07-02 | 2,970 | — | $0 | 59,061 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | J Other | 2015-05-06 | 2015-05-07 | 9,903 | — | $0 | 62,031 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion deriv | 2014-02-18 | 2014-02-20 | 569,538 | — | $0 | 0 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion deriv | 2014-02-18 | 2014-02-20 | 850,520 | — | $0 | 0 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion deriv | 2014-02-18 | 2014-02-20 | 1,028,613 | — | $0 | 0 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion deriv | 2014-02-18 | 2014-02-20 | 1,927,986 | — | $0 | 0 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | X Exercise deriv | 2014-02-18 | 2014-02-20 | 1,614 | — | $0 | 0 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion deriv | 2014-02-18 | 2014-02-20 | 9,359 | — | $0 | 0 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion deriv | 2014-02-18 | 2014-02-20 | 62,575 | — | $0 | 0 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | X Exercise deriv | 2014-02-18 | 2014-02-20 | 98,368 | — | $0 | 0 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | P Buy | 2014-02-18 | 2014-02-20 | 333,333 | $15.00 | $5.00M | 4,770,828 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion | 2014-02-18 | 2014-02-20 | 9,359 | — | $0 | 72,291 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | X Exercise | 2014-02-18 | 2014-02-20 | 21,837 | — | $0 | 4,437,495 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion | 2014-02-18 | 2014-02-20 | 569,538 | — | $0 | 4,415,658 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion | 2014-02-18 | 2014-02-20 | 1,927,986 | — | $0 | 1,966,987 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | X Exercise | 2014-02-18 | 2014-02-20 | 357 | — | $0 | 72,291 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion | 2014-02-18 | 2014-02-20 | 62,575 | — | $0 | 71,934 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion | 2014-02-18 | 2014-02-20 | 1,028,616 | — | $0 | 2,995,600 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion | 2014-02-18 | 2014-02-20 | 850,520 | — | $0 | 3,846,120 | SEC↗ |